PL EN


Preferences help
enabled [disable] Abstract
Number of results
2002 | 56 | 5 | 603-616
Article title

The role of membrane glycoproteins CD46, CD55 and CD59 in protection of tumor cells against complement lysis

Title variants
Languages of publication
PL
Abstracts
EN
Utilization of the complement system offers potential for the elimination of tumor cells by monoclonal antibodies (mAb) immunotherapy. Activation of the complement system causes tumor cell destruction by inducing complement lysis and promoting cell ? mediated killing. In addition, complement can induce a strong inflammatory response, which might enhance other antitumor effector mechanisms. An important targets for mAb immunotherapy, however, are membrane bound complement regulatory glycoprotein: CD46, CD55 and CD59, which have been found to be expressed on most tumor cells in vivo and in vitro. Blocking or downregulation of these inhibitors could be an important step in the advancement of mAb immunotherapy.
Keywords
Publisher

Year
Volume
56
Issue
5
Pages
603-616
Physical description
Contributors
author
author
author
References
Document Type
ARTICLE
Publication order reference
D. Wojnicz, Katedra i Zaklad Biologii i Parazytologii Lekarskiej AM, ul. Mikulicza-Radeckiego 9, 50-367 Wroclaw, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-34e3cccb-c47a-3519-8073-6240f9efa79a
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.